The present invention relates to an easy to administer topical lip balm/ointment composition for quickly healing fever blisters caused by the HSV-1 virus. The lip balm/ointment is topically applied to an affected area using a fingertip, or rolling a composition stick, and is penetrated deep into the skin for blocking the virus and protecting healthy skin cells. The composition includes a unique formulation of natural and organic ingredients consisting of beeswax, shea butter, liquid coconut oil, organic lemon or peppermint flavor, menthol, and colloidal silver. The composition heals the cold sore within 48 hours without using any harmful chemicals available in over-the-counter pharmacy products. The composition is available in small containers or rolling sticks.

An antibacterial medical biomaterial includes an acellular small intestinal submucosal matrix material, an antibacterial gel layer located on a surface of the acellular small intestinal submucosal matrix material, and an absorbable fiber layer located on a surface of the antibacterial gel layer. Sulfadiazine silver is on the surface of the acellular small intestinal submucosal matrix material and/or within the acellular small intestinal submucosal matrix material. An absorbable fiber layer to which the sulfadiazine silver is attached, wherein the content of sulfadiazine silver in the absorbable fiber is 1 wt. %˜2 wt. %. The medical biomaterial is usable as an external medicine for treating wound infections relayed by burns or wounds, and for reducing the incidence of infection by using a conventional central venous catheter with a sulfadiazine silver antibacterial coating, so that the medical biomaterial loaded with sulfadiazine silver also has antibacterial activity consistent with sulfadiazine silver.

An antibacterial medical biomaterial includes an acellular small intestinal submucosal matrix material, an antibacterial gel layer located on a surface of the acellular small intestinal submucosal matrix material, and an absorbable fiber layer located on a surface of the antibacterial gel layer. Sulfadiazine silver is on the surface of the acellular small intestinal submucosal matrix material and/or within the acellular small intestinal submucosal matrix material. An absorbable fiber layer to which the sulfadiazine silver is attached, wherein the content of sulfadiazine silver in the absorbable fiber is 1 wt. %˜2 wt. %. The medical biomaterial is usable as an external medicine for treating wound infections relayed by burns or wounds, and for reducing the incidence of infection by using a conventional central venous catheter with a sulfadiazine silver antibacterial coating, so that the medical biomaterial loaded with sulfadiazine silver also has antibacterial activity consistent with sulfadiazine silver.

The present invention provides agents having efficacy against viruses, allergens, bacteria and odorants, materials including such agents, and methods for producing the agents. An agent according to an embodiment of the present invention includes titanium dioxide particles having low photocatalytic activity, and metal ions of at least one metal selected from gold, silver, platinum and copper that are adsorbed to the surface of the titanium dioxide particles. The agent may further include hydroxyapatite particles, and the metal ions may be adsorbed also to the surface of the hydroxyapatite. The metal ions may be at least partially present in the form of at least one of an oxide of the metal, a hydroxide of the metal, and the elemental metal.

The present invention provides agents having efficacy against viruses, allergens, bacteria and odorants, materials including such agents, and methods for producing the agents. An agent according to an embodiment of the present invention includes titanium dioxide particles having low photocatalytic activity, and metal ions of at least one metal selected from gold, silver, platinum and copper that are adsorbed to the surface of the titanium dioxide particles. The agent may further include hydroxyapatite particles, and the metal ions may be adsorbed also to the surface of the hydroxyapatite. The metal ions may be at least partially present in the form of at least one of an oxide of the metal, a hydroxide of the metal, and the elemental metal.

The present invention is a formulation of organic and non-organic components for rapid wound healing and control of infection. The components of the present invention i.e. the formulation are an antimicrobial agent, an antioxidant, a cell proliferation inducing factor and an organic component responsible for matrix formation. Adding these four components in pre-determined proportions, formulations can be made for gels, liquid solution and biodegradable scaffolds which are safe and gives a synergistic effect.

The present invention is a formulation of organic and non-organic components for rapid wound healing and control of infection. The components of the present invention i.e. the formulation are an antimicrobial agent, an antioxidant, a cell proliferation inducing factor and an organic component responsible for matrix formation. Adding these four components in pre-determined proportions, formulations can be made for gels, liquid solution and biodegradable scaffolds which are safe and gives a synergistic effect.

A method of making Cu—Ag.sub.3PO.sub.4 nanoparticles is provided. The method includes forming a mixture of at least one silver salt, at least one phosphate salt, and at least one copper (II) salt. The method further includes dissolving the mixture in water. The method further includes sonicating the mixture. The method further includes precipitating the Cu—Ag.sub.3PO.sub.4 nanoparticles or “nanoparticles”. The copper is present in the nanoparticles in an amount of 2 to 23 weight percent (wt.%) based on the total weight of the Cu—Ag.sub.3PO.sub.4. The nanoparticles of the present disclosure find application in treating cervical cancer, and colorectal cancer. The nanoparticles may also be used in photodegrading environmental pollutants.

A method of making Cu—Ag.sub.3PO.sub.4 nanoparticles is provided. The method includes forming a mixture of at least one silver salt, at least one phosphate salt, and at least one copper (II) salt. The method further includes dissolving the mixture in water. The method further includes sonicating the mixture. The method further includes precipitating the Cu—Ag.sub.3PO.sub.4 nanoparticles or “nanoparticles”. The copper is present in the nanoparticles in an amount of 2 to 23 weight percent (wt.%) based on the total weight of the Cu—Ag.sub.3PO.sub.4. The nanoparticles of the present disclosure find application in treating cervical cancer, and colorectal cancer. The nanoparticles may also be used in photodegrading environmental pollutants.

The present invention provides compositions for delivering cannabinoids to the nasal cavity. The subject invention utilizes a composition comprising one or more cannabinoids and an adjuvant mixture to enhance the delivery of the cannabinoid, benefitting the subject to whom the cannabinoid is delivered.